Thomas N. Vilches

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

0in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 10 papers. Top paper: “The Impact of Vaccination on Coronavirus Disease 2019 (COVID-19) Outbreaks in the United States”.

The Impact of Vaccination on Coronavirus Disease 2019 (COVID-19) Outbreaks in the United States

Clinical Infectious Diseases(2021)10.1093/cid/ciab079

N/A

0DataRank · unranked

596 citations

Thomas N. Vilches, Kevin Zhang, Chad R. Wells, Affan Shoukat, Burton H. Singer +6 more

Evaluation of COVID-19 vaccination strategies with a delayed second dose

PLoS Biology(2021)10.1371/journal.pbio.3001211

N/A

0DataRank · unranked

160 citations

Thomas N. Vilches, Kevin Zhang, Shokoofeh Nourbakhsh, Pratha Sah, Meagan C. Fitzpatrick +2 more

Accelerated vaccine rollout is imperative to mitigate highly transmissible COVID-19 variants

EClinicalMedicine(2021)10.1016/j.eclinm.2021.100865

N/A

0DataRank · unranked

128 citations

Thomas N. Vilches, Seyed M. Moghadas, Meagan C. Fitzpatrick, Burton H. Singer, Peter J. Hotez +2 more

Multifaceted strategies for the control of COVID-19 outbreaks in long-term care facilities in Ontario, Canada

Preventive Medicine(2021)10.1016/j.ypmed.2021.106564

N/A

0DataRank · unranked

61 citations

Shokoofeh Nourbakhsh, Kevin Zhang, Lyndon Juden-Kelly, Lauren E. Cipriano, Joanne M. Langley +4 more

COVID-19 hospitalizations and deaths averted under an accelerated vaccination program in northeastern and southern regions of the USA

The Lancet Regional Health - Americas(2021)10.1016/j.lana.2021.100147

N/A

0DataRank · unranked

37 citations

Pratha Sah, Seyed M. Moghadas, Affan Shoukat, Meagan C. Fitzpatrick, Peter J. Hotez +3 more

Can the USA return to pre-COVID-19 normal by July 4?

The Lancet Infectious Diseases(2021)10.1016/s1473-3099(21)00324-8

N/A

0DataRank · unranked

12 citations

Pratha Sah, Thomas N. Vilches, Alison P. Galvani, Seyed M. Moghadas

Evaluation of COVID-19 vaccination strategies with a delayed second dose

medRxiv(2021)10.1101/2021.01.27.21250619

N/A

0DataRank · unranked

40 citations

Thomas N. Vilches, Kevin Zhang, Shokoofeh Nourbakhsh, Pratha Sah, Meagan C. Fitzpatrick +2 more

Quantifying the potential dominance of immune-evading SARS-CoV-2 variants in the United States

medRxiv(2021)10.1101/2021.05.10.21256996

N/A

0DataRank · unranked

6 citations

Thomas N. Vilches, Affan Shoukat, Meagan C. Fitzpatrick, Abhishek Pandey, Burton H. Singer +3 more

Modelling the impact of a high-uptake bivalent booster scenario on the COVID-19 burden and healthcare costs in New York City

The Lancet Regional Health - Americas(2023)10.1016/j.lana.2023.100555

N/A

0DataRank · unranked

11 citations

Meagan C. Fitzpatrick, Seyed M. Moghadas, Thomas N. Vilches, Charles Ko, Ashwin Vasan +2 more

Estimated US Pediatric Hospitalizations and School Absenteeism Associated With Accelerated COVID-19 Bivalent Booster Vaccination

JAMA Network Open(2023)10.1001/jamanetworkopen.2023.13586

N/A

0DataRank · unranked

3 citations

Seyed M. Moghadas, Thomas N. Vilches, Arnav Shah, Abhishek Pandey, Alison P. Galvani +1 more